Drug-coated balloon angioplasty for dialysis access fistula stenosis

Agence de la, 2013, Réseau épidémiologie, information néphrologie (REIN)

Riella, 2013, Vascular access in haemodialysis: strengthening the Achilles׳ heel, Nat Rev Nephrol, 9, 348, 10.1038/nrneph.2013.76

Fluck, 2011, Renal Association Clinical Practice Guideline on vascular access for haemodialysis, Nephron Clin Pract, 118, c225, 10.1159/000328071

Sidawy, 2008, The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access, J Vasc Surg, 48, 2S, 10.1016/j.jvs.2008.08.042

Jindal, 2006, Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology, J Am Soc Nephrol, 17, S1

Kukita, 2015, 2011 update Japanese Society for Dialysis Therapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis, Ther Apher Dial, 19, 1, 10.1111/1744-9987.12296

Navuluri, 2009, The KDOQI 2006 Vascular Access Update and Fistula First Program Synopsis, Semin Intervent Radiol, 26, 122, 10.1055/s-0029-1222455

Xue, 2013, Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications, Am J Kidney Dis, 61, 123, 10.1053/j.ajkd.2012.09.006

Polkinghorne, 2004, Vascular access and all-cause mortality: a propensity score analysis, J Am Soc Nephrol, 15, 477, 10.1097/01.ASN.0000109668.05157.05

Xue, 2003, The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients, Am J Kidney Dis, 42, 1013, 10.1016/j.ajkd.2003.07.004

Dhingra, 2001, Type of vascular access and mortality in U.S. hemodialysis patients, Kidney Int, 60, 1443, 10.1046/j.1523-1755.2001.00947.x

Woods, 1997, Vascular access survival among incident hemodialysis patients in the United States, Am J Kidney Dis, 30, 50, 10.1016/S0272-6386(97)90564-3

Glanz, 1987, The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas, Ann Surg, 206, 777, 10.1097/00000658-198712000-00015

Burger, 1990, Percutaneous transluminal angioplasty improves longevity in fistulae and shunts for haemodialysis, Nephrol Dial Transplant, 5, 608, 10.1093/ndt/5.8.608

Mori, 1994, Stenotic lesions in vascular access: treatment with transluminal angioplasty using high-pressure balloons, Intern Med, 33, 284, 10.2169/internalmedicine.33.284

Roy-Chaudhury, 2003, Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies, Blood Purif, 21, 99, 10.1159/000067863

Nesrallah, 2013, Canadian Society of Nephrology guidelines for the management of patients with ESRD treated with intensive hemodialysis, Am J Kidney Dis, 62, 187, 10.1053/j.ajkd.2013.02.351

Tonelli, 2001, Screening for subclinical stenosis in native vessel arteriovenous fistulae, J Am Soc Nephrol, 12, 1729, 10.1681/ASN.V1281729

Agarwal, 2015, Comparison of cutting balloon angioplasty and percutaneous balloon angioplasty of arteriovenous fistula stenosis: a meta-analysis and systematic review of randomized clinical trials, J Interv Cardiol, 28, 288, 10.1111/joic.12202

Aftab, 2014, Randomized clinical trial of cutting balloon angioplasty versus high-pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty, J Vasc Interv Radiol, 25, 190, 10.1016/j.jvir.2013.10.020

Kitrou, 2015, Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial, J Vasc Interv Radiol, 26, 348, 10.1016/j.jvir.2014.11.003

Patanè, 2014, Drug-eluting balloon for the treatment of failing hemodialytic radiocephalic arteriovenous fistulas: our experience in the treatment of juxta-anastomotic stenosis, J Vasc Access, 15, 338, 10.5301/jva.5000211

Khawaja, 2016, Systematic review of drug eluting balloon angioplasty for arteriovenous haemodialysis access stenosis, J Vasc Access, 17, 103, 10.5301/jva.5000508

Lai, 2014, Percutaneous angioplasty using a paclitaxel-coated balloon improves target lesion restenosis on inflow lesions of autogenous radiocephalic fistulas: a pilot study, J Vasc Interv Radiol, 25, 535, 10.1016/j.jvir.2013.12.014

Swinnen, 2015, Paclitaxel drug-eluting balloons to recurrent in-stent stenoses in autogenous dialysis fistulas: a retrospective study, J Vasc Access, 16, 388, 10.5301/jva.5000396

Kitrou, 2015, Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472), Eur J Radiol, 84, 418, 10.1016/j.ejrad.2014.11.037

Katsanos, 2012, Paclitaxel-coated balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial, J Endovasc Ther, 19, 263, 10.1583/11-3690.1

Massmann, 2015, Paclitaxel-coated balloon angioplasty for symptomatic central vein restenosis in patients with hemodialysis fistulas, J Endovasc Ther, 22, 74, 10.1177/1526602814566907

Tessitore, 2004, Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study, Nephrol Dial Transplant, 19, 2325, 10.1093/ndt/gfh316

Tonelli, 2002, Access flow monitoring of patients with native vessel arteriovenous fistulae and previous angioplasty, J Am Soc Nephrol, 13, 2969, 10.1097/01.ASN.0000040597.94103.48

Roy-Chaudhury, 2009, Cellular phenotypes in human stenotic lesions from haemodialysis vascular access, Nephrol Dial Transplant, 24, 2786, 10.1093/ndt/gfn708

Roy-Chaudhury, 2007, Neointimal hyperplasia in early arteriovenous fistula failure, Am J Kidney Dis, 50, 782, 10.1053/j.ajkd.2007.07.019

Stracke, 2002, Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas, Kidney Int, 61, 1011, 10.1046/j.1523-1755.2002.00191.x

Roy-Chaudhury, 2006, Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint, J Am Soc Nephrol, 17, 1112, 10.1681/ASN.2005050615

Langer, 2010, Chronic kidney disease aggravates arteriovenous fistula damage in rats, Kidney Int, 78, 1312, 10.1038/ki.2010.353

Kokubo, 2009, CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas, J Am Soc Nephrol, 20, 1236, 10.1681/ASN.2007121312

Lehoux, 2006, Molecular mechanisms of the vascular responses to haemodynamic forces, J Intern Med, 259, 381, 10.1111/j.1365-2796.2006.01624.x

Castier, 2005, p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling, Circ Res, 97, 533, 10.1161/01.RES.0000181759.63239.21

Lee, 2009, Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis, Adv Chronic Kidney Dis, 16, 329, 10.1053/j.ackd.2009.06.009

Tessitore, 2003, A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival, J Am Soc Nephrol, 14, 1623, 10.1097/01.ASN.0000069218.31647.39

Maya, 2004, Vascular access stenosis: comparison of arteriovenous grafts and fistulas, Am J Kidney Dis, 44, 859, 10.1016/S0272-6386(04)01085-6

Manns, 2005, Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis, J Am Soc Nephrol, 16, 201, 10.1681/ASN.2004050355

Ortega, 2005, The timely construction of arteriovenous fistulae: a key to reducing morbidity and mortality and to improving cost management, Nephrol Dial Transplant, 20, 598, 10.1093/ndt/gfh644

Stolic, 2013, Most important chronic complications of arteriovenous fistulas for hemodialysis, Med Princ Pract, 22, 220, 10.1159/000343669

Byrne, 2014, Drug-coated balloon therapy in coronary and peripheral artery disease, Nat Rev Cardiol, 11, 13, 10.1038/nrcardio.2013.165

Tepe, 2015, Angioplasty of femoro-popliteal arteries with drug-coated balloons. 5-Year follow-up of the THUNDER Trial, JACC Cardiovasc Interv, 8, 102, 10.1016/j.jcin.2014.07.023

Siablis, 2014, Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial, JACC Cardiovasc Interv, 7, 1048, 10.1016/j.jcin.2014.04.015

Liistro, 2013, Drug-eluting balloon in peripheral intervention for the superficial femoral artery. The DEBATE-SFA Randomized Trial (Drug Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery), JACC Cardiovasc Interv, 6, 1295, 10.1016/j.jcin.2013.07.010

Scheinert, 2015, Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BILUX P-I Randomized trial, J Endovasc Ther, 22, 14, 10.1177/1526602814564383

Liistro, 2014, Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study, J Endovasc Ther, 21, 1, 10.1583/13-4420R.1

Tepe, 2015, Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease. 12-Month results from the IN.PACT SFA Randomized Trial, Circulation, 131, 495, 10.1161/CIRCULATIONAHA.114.011004

Liistro, 2013, Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK). A randomized trial in diabetic patients with critical limb ischemia, Circulation, 128, 615, 10.1161/CIRCULATIONAHA.113.001811

Werk, 2012, Paclitaxel-coated balloons reduce restenosis after femoropopliteal angioplasty. Evidence from the Randomized PACIFIER Trial, Circ Cardiovasc Interv, 5, 831, 10.1161/CIRCINTERVENTIONS.112.971630

Cassese, 2012, Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials, Circ Cardiovasc Interv, 5, 582, 10.1161/CIRCINTERVENTIONS.112.969972

Schroeder, 2015, Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study, Catheter Cardiovasc Interv, 86, 278, 10.1002/ccd.25900

Byrne, 2013, Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial, Lancet, 381, 461, 10.1016/S0140-6736(12)61964-3

Zeller, 2014, Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia. 12-month results from the IN.PACT DEEP randomized trial, J Am Coll Cardiol, 64, 1568, 10.1016/j.jacc.2014.06.1198

Speck, 2012, Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel?, Circ Cardiovasc Interv, 5, 392, 10.1161/CIRCINTERVENTIONS.111.967794

Axel, 1997, Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery, Circulation, 96, 636, 10.1161/01.CIR.96.2.636

Cremers, 2014, Inhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter, Catheter Cardiovasc Interv, 84, 1089, 10.1002/ccd.25296

Hou, 2000, Intrapericardial paclitaxel delivery inhibits neointimal proliferation and promotes arterial enlargement after porcine coronary overstretch, Circulation, 102, 1575, 10.1161/01.CIR.102.13.1575

Albrecht, 2007, Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine, Invest Radiol, 42, 579, 10.1097/RLI.0b013e31804f5a60

Tepe, 2008, Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg, N Engl J Med, 358, 689, 10.1056/NEJMoa0706356

Werk, 2008, inhibition of restenosis in femoropopliteal arteries. Paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial, Circulation, 118, 1358, 10.1161/CIRCULATIONAHA.107.735985

Granada, 2014, Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing, Open Heart, 1, e000117, 10.1136/openhrt-2014-000117

Kearns, 2013, Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease, Br J Surg, 100, 1180, 10.1002/bjs.9195

Diehm, 2013, Cost-effectiveness analysis of paclitaxel-coated balloons for endovascular therapy of femoropopliteal arterial obstructions, J Endovasc Ther, 20, 819, 10.1583/13-4416R.1

Zeller, 2015, JACC Cardiovasc Interv, 8, 1614, 10.1016/j.jcin.2015.07.011

Karunanithy, 2016, Paclitaxel-coated balloon fistuloplasty versus plain balloon fistuloplasty only to preserve the patency of arteriovenous fistulae used for haemodialysis (PAVE): study protocol for a randomised controlled trial, Trials, 17, 241, 10.1186/s13063-016-1372-7